News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Jeff Molter: I’m starting a new position as Health communications consultant at Self
Jeff Molter/LinkedIn
Apr 3, 2025, 03:37

Jeff Molter: I’m starting a new position as Health communications consultant at Self

Jeff Molter, Former Director of Cancer/Institute Communications at NYU Langone Health, shared a post on LinkedIn:

“I’m happy to share that I’m starting a new position as Health communications consultant at Self., including work with the Museum of Medicine and Biomedical Discovery.”

cancer Jeff Molter Museum of Medicine and Biomedical Discovery OncoDaily Oncology Self.
Special Coverage
Blog
Apr 25, 2025, 11:31
Norman Ng: How should healthcare in Hong Kong develop?
Blog
Apr 25, 2025, 11:15
Amol Akhade: Data to look forward in AACR2025
Blog
Apr 25, 2025, 11:05
MD Anderson researchers are set to present breakthrough findings at the 2025 AACR Annual Meeting
Science
Apr 25, 2025, 10:57
Triparna Sen: Lipid Metabolism Remodeling and Ferroptosis Priming in Lung Adenocarcinoma
Blog
Apr 25, 2025, 10:42
True leadership is about bringing people and organizations together to create lasting change - American Cancer Society
Blog
Apr 25, 2025, 10:32
ASCO received the Dorothy Schachne Partners in Progress Award at CancerCare
Blog
Apr 25, 2025, 09:57
What to Expect at the AACR Annual Meeting 2025: Key Highlights and Must-Attend Sessions​
Blog
Apr 25, 2025, 09:24
Shankar Siva Supports Andrea Bezjak as Candidate for IASLC Presidency
Blog
Apr 25, 2025, 09:19
Julia Kiselka: I had the incredible opportunity to defend my Master’s thesis
Blog
Apr 25, 2025, 09:03
AIEOP is proud to support "Clinical Trial Day"
Blog
Apr 25, 2025, 08:56
Boris Pasche: Karmanos Cancer Institute Adds New SPECT/CT for Cancer Care
Science
Apr 25, 2025, 08:50
Nikhil Vojjala: Consideration of Pneumonectomy in the Era of Chemo-Immunotherapy in Resectable NSCLC